Found: 2
Select item for more details and to access through your institution.
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241274592
- By:
- Publication type:
- Article
Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2256, doi. 10.1002/cncr.34687
- By:
- Publication type:
- Article